ahlam1399
08-25-2016, 05:13 PM
BRIEF-Neuroderm initiates patient enrollment in a phase III trial of ND0612l for treatment of Parkinson?s disease
* Neuroderm initiates patient enrollment in a phase iiitrial of nd0612l for treatment of parkinson's diseasehttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=fWGXfk5Wn8I:ZCqdPrrZ8gU:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=fWGXfk5Wn8I:ZCqdPrrZ8gU:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=fWGXfk5Wn8I:ZCqdPrrZ8gU:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=fWGXfk5Wn8I:ZCqdPrrZ8gU:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=fWGXfk5Wn8I:ZCqdPrrZ8gU:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/fWGXfk5Wn8I
* Neuroderm initiates patient enrollment in a phase iiitrial of nd0612l for treatment of parkinson's diseasehttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=fWGXfk5Wn8I:ZCqdPrrZ8gU:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=fWGXfk5Wn8I:ZCqdPrrZ8gU:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=fWGXfk5Wn8I:ZCqdPrrZ8gU:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=fWGXfk5Wn8I:ZCqdPrrZ8gU:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=fWGXfk5Wn8I:ZCqdPrrZ8gU:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/fWGXfk5Wn8I